Table 1.
ALS participants | PLS participants | Controls | Total | |
---|---|---|---|---|
Number of participants (female/male) | 18 (8/10) | 5 (2/3) | 22 (12/10) | 45 (23/22) |
Age, mean (SD) | 57.6 (11.7) | 58.8 (2.6) | 56.6 (8.8) | 57.3 (9.6) |
Limb onset: bulbar onset (for ALS cases) | 15:3 | – | – | – |
ALSFRS-R score, mean (SD) | 34.53 (7.5) | 34.40 (3.2) | N/A | N/A |
Estimated progression rate (ALSFRS-R point loss per month), mean (SD) | 0.52 (0.37) | 0.25 (0.14) | N/A | N/A |
Disease duration in months from symptom onset, mean (SD) | 37.4 (27.0) | 86.9 (79.4) | N/A | N/A |
ALS = amyotrophic lateral sclerosis; ALSFRS-R = ALS Functional Rating Scale-Revised; PLS = primary lateral sclerosis; SD = standard deviation.